Testing effectiveness (Phase 2)Study completedNCT03535168What this trial is testingRepeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough PatientsWho this might be right forCough Bayer 59
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07567274What this trial is testingDMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine InjuryWho this might be right forTinnitus Leading Edge Clinic 20
Large-scale testing (Phase 3)Study completedNCT00425620What this trial is testingAmphotericin B Suspension in Refractory Chronic SinusitisWho this might be right forChronic Sinusitis Accentia Biopharmaceuticals 300
Testing effectiveness (Phase 2)Study completedNCT00104858What this trial is testingFludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+6 more Fred Hutchinson Cancer Center 66
Testing effectiveness (Phase 2)UnknownNCT03083574What this trial is testingExtracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)Who this might be right forRefractory Chronic Graft Versus Host Disease (cGVHD) Jules Bordet Institute 100
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT00278213What this trial is testingCombination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic LeukemiaWho this might be right forProlymphocytic Leukemia German CLL Study Group 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976What this trial is testingAzacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaWho this might be right forChronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more National Cancer Institute (NCI) 282
Early research (Phase 1)Active Not RecruitingNCT03479268What this trial is testingPevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin LymphomaWho this might be right forB-Cell Prolymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+15 more City of Hope Medical Center 18
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Not applicableStudy completedNCT03251703What this trial is testingUltrasound-Guided Suprascapular Pulsed RadiofrequencyWho this might be right forPAIN, INTRACTABLE, Shoulder Sakarya University 74
Testing effectiveness (Phase 2)Looking for participantsNCT06644183What this trial is testingRoginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemiaRelapsed LeukemiaChronic Lymphocytic Leukemia+2 more Jennifer R. Brown, MD, PhD 64
Testing effectiveness (Phase 2)Study completedNCT01392079What this trial is testingSubcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to FludarabineWho this might be right forChronic Lymphocytic Leukemia University of Ulm 135
Testing effectiveness (Phase 2)Looking for participantsNCT02918188What this trial is testingTherapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHDWho this might be right forChronic Graft-versus-host Disease Navy General Hospital, Beijing 21
Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00388362What this trial is testingSirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host DiseaseWho this might be right forGraft vs Host Disease Stanford University 36
Testing effectiveness (Phase 2)Study completedNCT02061761What this trial is testingEvaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell MalignanciesWho this might be right forHematologic Neoplasms Bristol-Myers Squibb 106
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Not applicableStudy completedNCT05174572What this trial is testingIMR Evaluation in Patients with Coronary Sinus Reducer Implantation (INROAD Study)Who this might be right forRefractory Angina Pectoris Consorzio Futuro in Ricerca 21
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1